Savara Inc. (SVRA)
NASDAQ: SVRA · Real-Time Price · USD
6.50
+0.13 (2.04%)
Dec 5, 2025, 4:00 PM EST - Market closed
Savara Employees
Savara had 59 employees as of December 31, 2024. The number of employees increased by 22 or 59.46% compared to the previous year.
Employees
59
Change (1Y)
22
Growth (1Y)
59.46%
Revenue / Employee
n/a
Profits / Employee
-$1,960,085
Market Cap
1.57B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
SVRA News
- 3 days ago - Savara and PARI Granted a European Patent Covering the Drug-Device Combination of MOLBREEVI* Delivered Via the Proprietary eFlow® Nebulizer System - Business Wire
- 15 days ago - Savara Announces Participation in Upcoming Investor Healthcare Conferences - Business Wire
- 19 days ago - Savara: A High-Risk Opportunity - Seeking Alpha
- 23 days ago - Savara Reports Third Quarter 2025 Financial Results and Provides Business Update - Business Wire
- 4 weeks ago - The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of November 7, 2025 in Savara Inc. Lawsuit – SVRA - GlobeNewsWire
- 5 weeks ago - Savara Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares for Total Gross Proceeds of $149.5M - Business Wire
- 5 weeks ago - SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Savara - GlobeNewsWire
- 5 weeks ago - Savara Announces Pricing of $130.0 Million Public Offering of Common Stock and Pre-funded Warrants - Business Wire